COVID-19 emergency response assessment study: a prospective longitudinal survey of frontline doctors in the UK and Ireland - study protocol by Roberts, Tom et al.
        
Citation for published version:
Roberts, T, Daniels, J, Hulme, W, Horner, D, Lyttle, MD, Samuel, K, Graham, B, Hirst, R, Reynard, C, Barrett, M
& Carlton, E 2020, 'COVID-19 emergency response assessment study: a prospective longitudinal survey of
frontline doctors in the UK and Ireland - study protocol', BMJ Open, vol. 10, no. 8, e039851.
https://doi.org/10.1136/bmjopen-2020-039851
DOI:
10.1136/bmjopen-2020-039851
Publication date:
2020
Document Version
Publisher's PDF, also known as Version of record
Link to publication
Publisher Rights
CC BY-NC
University of Bath
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 22. Sep. 2020
1Roberts T, et al. BMJ Open 2020;10:e039851. doi:10.1136/bmjopen-2020-039851
Open access 
COVID-19 emergency response 
assessment study: a prospective 
longitudinal survey of frontline doctors 
in the UK and Ireland: study protocol
Tom Roberts   ,1,2 Jo Daniels,3 William Hulme,4 Daniel Horner,1,5 
Mark David Lyttle   ,2,6 Katie Samuel,7 Blair Graham,8,9 Robert Hirst,7 
Charles Reynard,10 Michael Barrett   ,11 Edward Carlton1,12
To cite: Roberts T, Daniels J, 
Hulme W, et al.  COVID-19 
emergency response 
assessment study: a prospective 
longitudinal survey of frontline 
doctors in the UK and Ireland: 
study protocol. BMJ Open 
2020;10:e039851. doi:10.1136/
bmjopen-2020-039851
 ► Prepublication history for 
this paper is available online. 
To view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2020- 
039851).
Received 28 April 2020
Revised 22 July 2020
Accepted 23 July 2020
For numbered affiliations see 
end of article.
Correspondence to
Dr Tom Roberts;  
 tomkieranroberts@ gmail. com
Protocol
© Author(s) (or their 
employer(s)) 2020. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published by 
BMJ.
ABSTRACT
Introduction The COVID-19 pandemic is putting an 
unprecedented strain on healthcare systems globally. 
The psychological impact on frontline doctors of dealing 
with the COVID-19 pandemic is currently unknown. This 
longitudinal professional survey aims to understand 
the evolving and cumulative effects of working during 
the COVID-19 outbreak on the psychological well- being 
of doctors working in emergency departments (ED), 
intensive care units (ICU) and anaesthetics during the 
pandemic.
Methods and analysis This study is a longitudinal 
questionnaire- based study with three predefined time 
points spanning the acceleration, peak and deceleration 
phases of the COVID-19 pandemic.
The primary outcomes are psychological distress and 
post- trauma stress as measured by the General Health 
Questionnaire-12 (GHQ-12) and Impact of Events Scale- 
Revised (IES- R). Data related to personal and professional 
characteristics will also be collected. Questionnaires 
will be administered prospectively to all doctors working 
in ED, ICU and anaesthetics in the UK and Ireland via 
existing research networks during the sampling period. 
Data from the questionnaires will be analysed to assess 
the prevalence and degree of psychological distress 
and trauma, and the nature of the relationship between 
personal and professional characteristics and the 
primary outcomes. Data will be described, analysed and 
disseminated at each time point; however, the primary 
endpoint will be psychological distress and trauma at the 
final time point.
Ethics and dissemination Ethical approval was obtained 
from the University of Bath, UK (ref: 4421), and Children’s 
Health Ireland at Crumlin, Ethics Committee. Regulatory 
approval from the Health Regulation Authority (UK), Health 
and Care Research Wales (IRAS: 281944).
This study is limited by the fact that it focuses on 
doctors only and is survey based without further 
qualitative interviews of participants. It is expected this 
study will provide clear evidence of the psychological 
impact of COVID-19 on doctors and will allow 
present and future planning to mitigate against any 
psychological impact.
Trial registration number ISRCTN10666798.
INTRODUCTION
Severe acute respiratory syndrome virus 
covariant 2 (SARS- CoV-2) is a presumed 
zoonotic novel coronavirus that first emerged 
in the province of Hubei, China, during late 
2019.1 Viral transmission is presumed to be 
via droplet spread and it multiplies in respi-
ratory epithelium. Clinical manifestations 
of the resulting COVID-19 disease include 
bilateral interstitial pneumonia, acute respi-
ratory distress syndrome and multiorgan 
dysfunction syndrome.2 Due to high trans-
missibility, hospitalisation rates, critical care 
requirements and mortality rate in elderly 
and vulnerable populations, COVID-19 has 
created a public health emergency3 and was 
declared a pandemic by the WHO on 11 
March 2020.4
Clinicians in acute and critical healthcare 
services provide medical care at the point 
of highest risk of disease transmission, and 
frequently undertake aerosol- generating 
procedures which increase their exposure 
Strengths and limitations of this study
 ► This longitudinal study will assess psychological 
well- being in frontline doctors, at three time points 
across the pandemic wave, providing novel data in 
this potentially at- risk group.
 ► Both the General Health Questionnaire-12 and the 
Impact of Events Scale- Revised have been previous-
ly used in infectious disease outbreaks to measure 
psychological distress and trauma response.
 ► Collection of data at the ‘peak’ phase, capturing the 
degree of distress and personal and profession-
al factors associated with distress at a prime time 
point of maximal stress on frontline doctors.
 ► Predetermined data collection points are reliant on 
national reporting and may not accurately reflect lo-
cal or regional variations in systems pressure.
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to SARS- CoV-2. During comparable infectious disease 
outbreaks such as SARS- CoV and Ebola, healthcare 
workers were over- represented in disease incidence 
and poor clinical outcomes. Such concerns relating 
to COVID-19 are reflected in experiences anecdotally 
reported from the international healthcare community.5
This study will focus on doctors and not the wider 
healthcare workforce. It is well documented that other 
professions are potentially impacted more by infectious 
disease outbreaks and by COVID-19.6 Discussions were 
held between the study team and representatives from 
the Royal College of Nursing UK and College of Para-
medics UK about a combined study. It was agreed that 
due to the limited timescale to collect data during the 
acceleration phase and complexities around different 
working practices that delaying data collection to involve 
a wider cohort would threaten the viability of the study. 
This protocol was shared with the colleges to support 
their independent studies, as well as ongoing information 
sharing to support study implementation.
In the UK and Ireland, doctors working in emer-
gency departments (ED), intensive care units (ICU) and 
anaesthetics will be responsible for the initial identifica-
tion, management and ongoing treatment of patients 
presenting with COVID-19. In addition, many difficult 
decisions relating to treatment escalation and resource 
allocation for individual patients will be made by clini-
cians working in these key areas. Many doctors are likely 
to be redeployed to these clinical areas or asked to 
work beyond their level of seniority. In addition, these 
doctors are likely to be directly responsible for the care of 
colleagues and staff members with the infection.
Resources in these clinical areas are already stretched 
at baseline. Operational pressures within EDs, critical 
care settings and emergency anaesthetic provision have 
been severe and escalating over a period of many years. 
This is reflected in the time to complete care episodes 
and health outcomes,7 the impact of fatigue and burnout 
within anaesthesia and ICU training,8 and the UK and 
Ireland having some of the lowest numbers of critical 
care beds per 100 000 of population in Europe.9 This has 
resulted in concerns regarding surge capacity of facili-
ties to cope with a pandemic illness.10 The psychological, 
emotional and physical demands placed on an already 
overstretched workforce may therefore be substantial.
It is evident from a substantial body of research across 
disaster settings that there is often a significant and long- 
lasting negative impact on the psychological well- being of 
clinicians involved.11 12 Similar themes are also emerging 
from the COVID-19 pandemic in a cross- sectional survey 
undertaken in selected healthcare workers in China.6
Key factors in predicting psychological distress post- 
trauma span a range of domains and include preparedness 
and training,13–15 social and occupational support,13–16 risk 
exposure and threat to life,14 16 17 self- isolation,14 16 18 media 
use,19 20 negative affect following exposure,14 16–18 history 
of mental health problems and previous trauma.15 17 18 
Yet, these have largely been identified post hoc, in the 
aftermath of events and without prospective data collec-
tion or a comprehensive understanding of the relative 
impact of these factors as an event unfolds.
To date, no large- scale longitudinal studies have 
proposed to prospectively examine the psychological 
distress and trauma response in clinicians during the accel-
eration, peak and deceleration phase of the pandemic 
wave of COVID-19. This study aims to understand the 
evolving and cumulative effects of working in EDs, ICUs 
and anaesthesia during the COVID-19 outbreak, specifi-
cally seeking to understand key personal and professional 
factors which predict psychological distress in this cohort 
of frontline doctors.
METHODS AND ANALYSIS
The primary aim of this study is to assess the prevalence 
and degree of psychological distress and trauma in doctors 
providing frontline care during the acceleration, peak 
and deceleration phases of the COVID-19 pandemic, and 
furthermore establish which personal and professional 
factors are associated with psychological distress at these 
time points.
More specifically, the objectives are to:
1. Evaluate personal and professional factors contrib-
uting to psychological well- being at the acceleration, 
peak and deceleration phase of the pandemic.
2. Establish the incidence of self- reported COVID-19 
infection and self- isolation among frontline doctors, 
and to evaluate any association with psychological well- 
being.
3. Assess regional and national variation of psychologi-
cal distress and trauma in doctors within the UK and 
Ireland.
Study design and conduct
This prospective online longitudinal survey consists 
of three phases commensurate with the fluctuation of 
an initial pandemic wave of COVID-19 in the UK and 
Ireland. More specifically,
 ► Phase 1: Acceleration survey; administered at 0 month 
(March 2020).
 ► Phase 2: Peak survey; administered on day 7 following 
the pandemic peak, as defined by COVID-19- related 
hospital deaths, in the UK and Ireland.
 ► Phase 3: Deceleration survey; administered 30 days 
following the peak survey.
These three phases have been adapted from the Centre 
for Disease Control (CDC) ‘Preparedness and Response 
Framework for Influenzae Pandemics’ (figure 1).21
Outcome measures
The coprimary outcome measures will be GHQ-12 scores 
from Phase 1, 2 and 3 surveys, and the IES- R score in 
Phase 2 and 3 surveys.
The General Health Questionnaire-12 (GHQ-12)22 is 
a brief, validated, 12- item self- report measure devised 
to screen for psychological distress in the general 
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population. It assesses current state (rather than long- 
standing attributes) and asks the participants to compare 
with the usual state. The measure has high specificity and 
sensitivity, with reliability demonstrated across a range of 
cultures and populations.23 The GHQ-12 has been used 
in similar clinician- based studies measuring the psycho-
logical impact of infectious outbreaks14 and was chosen 
due to the brevity of the measure and its suitability for 
time pressured medical staff. The GHQ-12 can be scored 
using several methods and we will report two of these 
in our results. The first, the 0-0-1-1 scoring method, is 
the most commonly used and has the highest sensitivity 
and specificity overall.23 This method has an established 
clinical cut- off of >3 which we will use to calculate prev-
alence of case level psychological distress in our study 
sample.23–25 The second uses a 0-1-2-3 scoring method 
which is sensitive to changes across time points; however, 
unlike the first method, there is no established cut- off 
and this technique reflects degree of distress rather than 
threshold caseness. We will use this method to detect 
within- person changes within our sample. By presenting 
the two different scoring methods, we can both report the 
prevalence of case level distress across the sample (0-0-1-1 
scoring method) and detect changes within the sample 
over the three phases of the pandemic (0-1-2-3 scoring 
method).
The Impact of Events Scale- Revised (IES- R)26 is a 22- item 
measure commonly used to measure post- traumatic stress 
following a prespecified traumatic incident. Items are 
scored on a Likert scale, ranging from 0 representing 
‘not at all’ to 4 representing ‘extremely’. The IES- R has 
been commonly used in infectious disease outbreaks to 
assess post- traumatic stress in hospital staff.14 The IES- R 
has three subscales, relating to intrusion, avoidance and 
hyperarousal. Responses will be analysed similar to the 
GHQ-12, assigning the responses as 0, 1, 2, 3, 4 (positive 
to negative) producing a score in the range 0–88. A score 
of 24 or above will indicate a clinically significant stress 
response.
Secondary outcome measures will be predefined 
personal and professional characteristics (table 1) and 
their association with psychological distress as defined by 
GHQ-12 and IES- R.
Participants
Frontline medical staff employed in their main role as 
a doctor in the ED, ICU or anaesthetics in the UK and 
Ireland at the point of study commencement will be 
invited to participate. All grades of medical staff will be 
eligible to participate.
Doctors who move clinical setting between surveys will 
not be excluded, provided they remain within an acute 
trust setting. Doctors whose main place of employment 
at the point of study commencement is not the ED, ICU 
or anaesthetics and non- doctors working in ED, ICU or 
anaesthetics will be excluded. Participants will be asked 
to declare the hospital they work in. Hospitals will be 
grouped into regions as defined by UK Government coro-
navirus death reporting.27
Survey distribution
All potential participants will be invited to participate 
in the Phase 1 survey through established acute care 
research networks: in emergency medicine, members 
of the Trainee Emergency Research Network (TERN), 
Irish Trainee Emergency Research Network (I- TERN), 
Irish Association of Emergency Medicine and Paediatric 
Emergency Research in the UK and Ireland (PERUKI) 
will be invited to register as participating sites via institu-
tional email and instant messaging groups. A site lead will 
be identified in each centre who will be responsible for 
distributing the participation link for the Phase 1 survey 
and encouraging participation through the display of 
relevant materials. In order to mitigate against non- UK or 
Ireland doctors and other healthcare groups completing 
Figure 1 Timing of surveys in accordance with pandemic preparedness model. Solid blue line represents date of survey issue, 
transparent blue area represents data collection period (as adapted from the Centre for Disease Control (CDC)21).
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Table 1 Personal and professional questions
Demographic data Survey 1 Survey 2 Survey 3
Age ✓     
Gender ✓     
Ethnicity   ✓   
Employment- related factors Survey 1 Survey 2 Survey 3
Name of hospital ✓     
Parent specialty ✓     
Type of department ✓     
Redeployed to another clinical area ✓ ✓   
Where have you been redeployed to ✓ ✓   
How satisfied are you with this redeployment ✓ ✓   
Deployment back to original place of work     ✓
Local availability of psychological support   ✓ ✓
Training and experience Survey 1 Survey 2 Survey 3
Previous infectious disease experience ✓     
Exposure to suspected/confirmed cases of COVID-19 ✓ ✓ ✓
Exposure to patients who have died due to suspected or confirmed COVID-19   ✓ ✓
Personal protective equipment training ✓ ✓   
Confidence in personal protective equipment training ✓ ✓ ✓
COVID-19 practical clinical care training and confidence ✓ ✓ ✓
Frequency of access and sources of clinical information ✓ ✓   
Perception of preparedness ✓ ✓ ✓
Personal factors Survey 1 Survey 2 Survey 3
Concern regarding worsening of mental health condition ✓ ✓ ✓
Concern regarding worsening of physical health condition ✓ ✓ ✓
Concerns about risk to personal health ✓ ✓ ✓
Concerns about risk to family or loved ones ✓ ✓ ✓
Experience of previous significant trauma (prior to COVID-19 pandemic)   ✓ ✓
Concern about risk of death to self   ✓ ✓
Perception of support from friends and family   ✓ ✓
Perception of support from senior leadership team   ✓ ✓
Perception of impact on other patient groups (not COVID-19) ✓ ✓ ✓
Positive factors related to involvement with coronavirus response   ✓ ✓
Personal experience of COVID-19 Survey 1 Survey 2 Survey 3
Have you had to self- isolate ✓ ✓ ✓
Reason for self- isolation ✓ ✓ ✓
Number of clinical shifts missed due to self- isolation ✓ ✓ ✓
Have you received a positive coronavirus diagnosis   ✓ ✓
Have you been admitted to hospital due to coronavirus   ✓ ✓
Have you received an antibody test     ✓
What was the result of the antibody test     ✓
Any COVID-19- related illness or death in family or friends   ✓ ✓
Any COVID-19- related illness or death in colleagues   ✓ ✓
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the survey, the participation link will not be shared on 
wider social media platforms.
In the fields of intensive care and anaesthesia, partici-
pants will be invited to complete the Phase 1 Survey via the 
UK Research and Audit Federation of Trainees (RAFT) 
network membership groups and the Irish Specialist 
Anaesthesiology Trainee Audit & Research Network 
(SATARN) via email and instant messaging. Addition-
ally, participation invitations will be disseminated by the 
Royal College of Anaesthetists, College of Anaesthesiolo-
gists of Ireland and National Institute of Health Research 
(NIHR) Clinical Research Networks (including trauma 
and emergency care, critical care and anaesthesia and 
perioperative medicine) via email to regional leads, 
with additional invitations to all UK anaesthetists via the 
Lifelong Learning Platform. The Trainee Research in 
Intensive Care network will also distribute the survey link 
among their members and through the Faculty of Inten-
sive Care Medicine.
Survey design
The survey has been designed and managed in line with 
the Checklist for Reporting Results of Internet E- surveys 
(CHERRIES) guidelines.28
A summary of survey construction is outlined in table 2. 
Each survey was developed iteratively by the study team 
and underpinned by evidence where available, or by 
consensus where necessary. Literature reviews were 
performed to identify factors with potential impact on 
psychological distress and trauma. Psychometric tools 
were selected by consensus of the study team, consid-
ering validity and utility of a range of measures, balanced 
against the feasibility of delivery and completion by indi-
viduals likely to be working at maximum capacity. Each 
survey will be piloted by members of the study team prior 
to full release.
Phase 1: acceleration survey
Phase 1 survey (online supplementary file 1) will gather 
consent and contact email address, selected personal and 
professional characteristics and responses to the GHQ-12 
survey.
Phase 2: peak survey
All participants who completed the Phase 1 survey will be 
invited via the REDCap invite function to complete Phase 
2 and 3 surveys. This uses a secure institutional email to 
deliver email invitations. The Phase 2 survey will gather 
consent and additional demographic, experiential or 
work- related data. No additional personal identifiable 
information will be taken. Participants will be requested 
to complete a serial evaluation of GHQ-12 and the IES- R; 
these are both valid and reliable short- form measures of 
their original counterparts and are used in order to limit 
participant fatigue.
Phase 3: deceleration survey
Phase 3 survey will gather consent and further data on 
personal and professional factors. No additional personal T
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identifiable information will be taken, and it will be 
ensured that the survey does not exceed a reasonable 
length, to limit participant fatigue. Participants will be 
requested to complete a serial evaluation of GHQ-12 and 
IES- R.
Survey timeline
Identification of pandemic phases to guide survey release
The surveys will be released in keeping with the CDC 
pandemic framework outlined in figure 1. As the current 
outbreak is dynamic by its very nature, the exact timings 
of the peak and deceleration phases are uncertain but 
will be identified using the below criteria.
Identification of acceleration phase
The authors reached a consensus decision on 17 March 
2020, based on best available evidence from Public Health 
England (PHE) that the UK was in the ‘acceleration 
phase’ of the current COVID-19 outbreak. Phase 1 survey 
was opened on 18 March 2020, for a period of 10 days.
Identification of peak phase
The authors will hold regular remote meetings to monitor 
the evolving COVID-19 outbreak. The ‘Peak’ survey will be 
released 7 days after the first UK and first Ireland national 
peaks of COVID-19- related deaths. The 7- day time delay 
is due to the requirement of the IES- R scale to reflect on 
feelings over the last 7 days, thus a delay will ensure that 
answers more accurately represent true outcomes from 
the pandemic peak. Nationally reported death rates have 
been chosen rather than confirmed cases due to a lack 
of consistency in screening and reporting of confirmed 
cases in the UK and Ireland. As UK national death rates 
are publicly available, in comparison to regional death 
rates, it is recognised that regional variation may occur.
The UK and Ireland national peaks will be decided by 
a consensus decision of the Study Management Group, 
which will be recorded and documented in the final study 
report. The consensus decision will be guided by:
 ► Publicly available COVID-19 daily death rates data 
from PHE (accessed via: https:// coronavirus. 
data. gov. uk) and Ireland’s Department of Health 
(accessed via: https://www. gov. ie/ en/ news/ 
7e0924- latest- updates- on- covid- 19- coronavirus/).
 ► Government daily briefings.
 ► Published modelling literature.
The survey will remain open for 14 days to ensure 
maximal response rates.
Identification of deceleration phase
The deceleration phase is defined by the CDC as ‘consis-
tently decreasing rate of cases’.21 To ensure the decelera-
tion survey is released during this phase, it will be released 
30 days after the administration of the ‘Peak’ survey. 
This is to ensure UK and Ireland cases are consistently 
decreasing and that there is no evidence of a second 
peak. The survey will remain open for 21 days.
Informed consent
Electronic informed consent will be obtained prior to 
completion of each round of the surveys.
Withdrawal
Participants can exit the survey online if they no longer 
wish to take part at any time. However, it will be clear 
in the introductory statement that data from questions 
already completed may be analysed.
Administration
The survey will be administered via the online platform 
REDCap. This electronic data capture platform is fully 
compliant with Good Clinical Practice, GDPR and 20 
ISO 27001. It has stringent data security procedures and 
uses private servers. Data will be held securely on secure 
online server hosted by the University Hospitals Bristol 
and Weston NHS foundation Trust, UK.
Patient and public involvement
Staff well- being was rated the fourth highest priority of 
the James Lind Alliance Priority Setting Partnership,29 
which involved extensive consultation with clinicians, 
patients, public and carers. This study does not directly 
involve patients; however, the potential impact that 
psychological trauma in doctors could have for patient 
care is concerning. Due to the urgency and unprec-
edented nature of the current situation, patient and 
public involvement directly related to this study has not 
been possible during the development of this protocol. 
It was felt inappropriate to seek stakeholder engagement 
from doctors over the short study development period as 
it could have detracted from pressing clinical demands.
STATISTICAL ANALYSIS PLAN
Response rate
This will be presented using the CHERRIES checklist 
specifications.28 An overall response rate denominator 
will be reported using the data provided by the General 
Medical Council on doctors currently registered and 
working in ED, anaesthetics and ICU in the UK. Estimates 
on the denominator for participants from Ireland will 
be reported using data provided by individual hospital 
departments on doctors working in the ED, anaesthetics 
and ICU.
Analysis cohort (inclusion/exclusion criteria)
Non- consented, duplicate (by email address) and non- 
completion of the minimum required dataset for anal-
ysis (completion of GHQ-12, grade and hospital) will be 
excluded. Duplicates are handled as follows: where two 
or more email addresses are present, the most complete 
survey will be taken. Note that a complete survey may 
include unanswered questions.
The primary analysis cohort will comprise participants 
who have completed the GHQ-12 in all three surveys and 
the IES- R in surveys 2 and 3. Subanalyses of completed 
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surveys 1, 2 and 3, irrespective of completion of other 
survey, will also be reported.
Due to the difference in COVID-19- related policy 
between the Governments of the UK and Ireland, there 
may be a difference in timing of the pandemic wave. This 
could result in a significant difference of the study popula-
tions. Therefore, a study management group decision will 
be made, prior to final analysis, in regard to whether the 
difference of timing of the UK and Ireland’s pandemic 
waves precludes joint analysis. Any decision will be docu-
mented in the final study report.
Descriptive statistics
Descriptive statistics relating to participants’ personal and 
professional characteristics will be presented overall and 
by department/geographical region.
GHQ-12 items will be analysed both individually and 
aggregated into an overall score using the 0-1-2-3 method. 
This method assigns responses to 0, 1, 2, 3 (positive to 
negative sentiment) producing a score in the range 0 to 
36, with 0 representing the most healthy response and 
36 the most unhealthy. Note that for case identification, 
the 0-0-1-1 method is used (see the Outcome measures 
section and table 3).
IES- R responses will be analysed similarly by assigning 
the responses to 0, 1, 2, 3, 4 (positive to negative), 
producing a score in the range of 0– 60.
The distribution of GHQ-12 and IES- R scores will be 
presented graphically, with an appropriate measure of 
central tendency and variation provided. Comparisons 
between different personal and professional characteris-
tics will also be made. Distributional (median, Q1, Q3) 
and mean differences will be reported. Proportions of 
respondents meeting thresholds of clinically significant 
impairment will be derived for each of the psychometric 
measures, as outlined in table 3.
These descriptive analyses will be performed for the 
primary analysis cohort and the survey- specific subco-
horts. Participant dropout rates from survey 1 to surveys 2 
and 3 will be reported.
Intersurvey analysis
The models outlined are descriptive, with model param-
eters intended to summarise observed statistical relation-
ships rather than estimating underlying causal effects. 
No formal null hypothesis significance testing will be 
performed to determine the presence or absence of 
statistically significant effect sizes, although p values for 
model estimates will be reported for reference.
Change in the GHQ-12 score
The change over time in the GHQ-12 score among partic-
ipants who responded to all three surveys will be exam-
ined. Graphical relationships between the trend in the 
GHQ-12 score and variables collected at Phase 1 survey 
will be presented.
A repeated measures non- linear mixed effect model 
will be deployed. The dependent variable, GHQ score 
as measured on three consecutive occasions, is indexed 
either by survey response date (in continuous time) or 
by survey epidemic phase (before, during and after the 
epidemic peak). Models based on both indices will be 
investigated.
For the time- indexed model, a quadratic relationship 
between time and GHQ will be permitted (given the 
potential for a rise then fall in GHQ-12 over the course 
of the epidemic).
Region- level random effects on the intercept and time 
will be included in both time- indexed and phase- indexed 
models, enabling regional differences in the modelled 
effect of phase/time on GHQ and IES- R scores to be 
(partially) accounted for. Hospital- level random effects 
may also be investigated, depending on the number of 
responses per hospital. While hospital- level random 
effects would more appropriately account for between- 
hospital heterogeneity than region- level random effects, 
it is anticipated that some hospitals will only be repre-
sented by only a very small number of participants, which 
may cause problems for model identification.
To identify potential modifiers of GHQ-12- score 
change, further models each with a single additional 
covariate will be built, with the likelihood ratio used to 
assess the degree of improvement in the model.
Impact of Events Scale-Revised
The IES- R score among participants who responded to all 
three surveys will be examined. Graphical relationships 
between the IES- R score and variables collected at survey 
1 will be presented.
A linear model will be deployed seeking to account for 
the variation in the IES- R score with survey 1 variables.
To identify potential prepeak modifiers of IES- R- score 
(for instance, to identify characteristics that put clinicians 
at higher risk of trauma following an epidemic), further 
models each with a single additional covariate will be 
built, and a likelihood ratio test performed to assess the 
improvement in the model. For Phase 3 models, the IES- R 
score from Phase 2 will also be included as a covariate.
Procedure for accounting for missing, unused and spurious 
data
Information on completeness for each variable will be 
reported. For the primary models, missing values will be 
Table 3 Threshold scores for the GHQ-12 and IES- R
Thresholds for clinical significance of each of 
the psychometric evaluations
GHQ-12
General 
Function
 ► Above 3 on the 0-0-1-1 scoring system 
represents case level psychological distress
IES- R
Trauma
 ► 24 or above on the 0-1-2-3-4 scoring 
system represents clinically significant stress 
response
GHQ-12, General Health Questionnaire-12; IES- R, Impact of 
Events Scale- Revised.
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imputed using multilevel fully conditional specification 
multiple imputation with 100 imputed datasets to be 
created.30–32 For consistency, the same imputed datasets 
will be used across all models. Categorical variables will be 
imputed using multinomial logistic regression and ordinal 
variables using ordinal regression. The only continuous 
variables are GHQ-12 score and IES- R but these will be 
derived anew following imputation of the individual ques-
tions and will not be imputed directly. Imputation will 
not be necessary for region, grade and specialty as these 
are complete by design due to the exclusion criteria. An 
‘impute- then- delete’ strategy will be employed for the 
dependent variable. Effect estimates across imputed data-
sets will be pooled using Rubin’s rules.33
Software
All analyses and statistical outputs will be produced in the 
statistical programming language R. The lme4 package 
will be used for the mixed- effects models.
Procedures for reporting any deviation(s) from the original 
statistical plan
Any requirement to deviate from the original statistical 
plan will be discussed with the Study Management Group 
and independently reviewed by an external statistician, 
where appropriate, and documented appropriately with a 
full explanation as to reasoning and requirement.
Data storage
Data will be stored electronically for 5 years by the Univer-
sity Hospital of Bristol and Weston NHS Foundation Trust.
ETHICS AND DISSEMINATION
Ethical approval
This project has ethical approval from the University of 
Bath, UK, and Children’s Health Ireland at Crumlin, 
Ethics Committee (online supplementary 2). Regula-
tory approval was obtained from the Health Regulation 
Authority (UK), Health and Care Research Wales (online 
supplementary 3).
Risk to participants
This survey collects potentially sensitive information, 
which will be handled in accordance with the General 
Data Protection Regulations. This includes details on 
participants’ baseline health status and psychometric 
evaluations of anxiety, depression and post- traumatic 
stress. It will be emphasised in the participant informa-
tion sheet that such measures are non- diagnostic and that 
the purpose of the study is to monitor psychological well- 
being on a population level. As scales are being used for 
non- diagnostic purposes, feedback will not be provided 
to participants regarding their scores. Participants will 
be given the option to not disclose existing physical or 
mental health complaints with these questions listed as 
‘optional’. It is possible that questions relating to personal 
health and well- being may trigger emotive responses in 
participants. Participants will be signposted to suggested 
local and national sources in the UK and Ireland where 
they may obtain support at the beginning and end of 
each survey.
Risk to investigators
There are no anticipated additional risks to investiga-
tors as part of this study. The study may generate media 
interest. All media releases will be conducted through the 
sponsor and/or publishing journals. Media interviews 
will be undertaken by a senior member of the study group 
with media training.
Dissemination
Interim study reports will be prepared for public dissem-
ination. On study completion, a final manuscript will be 
submitted to a peer- reviewed scientific journal and shared 
with Medical Royal Colleges to inform stakeholders of the 
pandemic impact on this critical workforce. The results 
will be disseminated widely at scientific conferences.
DISCUSSION
This large- scale prospective longitudinal survey of front-
line doctors builds on previous work regarding psycho-
logical well- being in acute care settings and looks to assess 
the psychological impact of the COVID-19 pandemic on 
frontline doctors, specifically seeking to understand key 
personal and professional factors which predict psycho-
logical distress in this cohort. Findings will be discussed 
in relation to the current context and in light of the 
reported impact of previous infectious disease outbreaks, 
aiming to contribute to novel data on frontline doctors’ 
mental health in a rapidly emerging field.
Concerns have been raised regarding the potential 
and likely negative psychological impact of increasing 
workload in the already stretched ED clinical environ-
ment, with anticipation that this will be exacerbated by 
the specific and significant challenges of work during the 
COVID-19 pandemic.34 35 In line with previous research, 
frontline healthcare workers are likely to be affected by 
fears of contamination, disruption of normal supportive 
structures and work stress.36 However, there is a paucity of 
data to quantify these effects. This collaborative research 
project, which harnesses the extensive reach of research 
networks, and supported by national professional bodies 
(such as the Medical Royal Colleges), seeks to address 
an important research question through rapid mobilisa-
tion of existing research infrastructures. The immediate 
outputs of this work will aim to inform the psycholog-
ical response to this infection wave and future infection 
waves by robustly assessing the degree of psychological 
distress and trauma in the frontline workforce, further-
more gaining a greater understanding of the potentially 
modifiable personal and professional factors that predict 
distress. Establishing need is imperative given that trauma 
and psychological distress has been repeatedly demon-
strated to have negative impact on occupational perfor-
mance, job satisfaction, physical and psychological.37–39 
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By robustly identifying predictive factors associated with 
mental health outcomes in this population, targets for 
intervention will be provided; treatment for trauma and 
psychological distress is evidence- based, efficacious and 
widely available on the NHS.40 Recent advancements in 
psychological therapy provision have expanded adapta-
tions for the frontline staff workforce41; however, there 
is currently a lack of knowledge concerning the precise 
prevalence and degree of distress and what characterises 
those who are most affected. This knowledge is essential 
to enable tailoring of support, treatment and pathways 
appropriate to the need. This research aims to address 
that gap and provide a foundation from which to shape 
service development in order to improve outcomes in this 
critical workforce.
The primary limitation to this work lies in estimating 
the peak phase and therefore the time point of maximal 
stress on frontline doctors. This is reliant on national 
reporting and may not reflect local or regional variations 
in systems pressure. However, given the high response 
rate and sample size in the acceleration phase survey, it is 
planned to mitigate regional effects through predefined 
subgroup analysis. Due to the rapidly developing nature of 
the pandemic, constraints have prevented the gathering 
of qualitative data as part of this study. Further research 
should explore the nature of distress in this population, 
drawing out themes that would enhance depth of knowl-
edge in this area. There is a risk of selection bias through 
participant dropout from survey 1 to surveys 2 and 3. To 
mitigate against this, the GHQ-12 and IES- R results for 
those who drop out will be presented in the final analysis.
A further limitation to this work is the lack of base-
line level of distress or trauma in this cohort prior to 
the COVID-19 pandemic. Work within the ED, ICU and 
anaesthetics is already known to be challenging and 
impact doctors’ psychological health.8 42 43 Results of this 
study will be presented in the context of the existing liter-
ature predating the COVID-19 pandemic.
In conclusion, this longitudinal professional survey 
aims to robustly assess the psychological impact of the 
COVID-19 pandemic on frontline doctors using sequen-
tial assessment to assess prevalence and degree of psycho-
logical distress across three key time points, defining 
the nature of the relationship between key personal and 
professional factors and primary outcomes of psycho-
logical distress and trauma response. This informa-
tion will provide vital understanding of the impact of 
the COVID-19 pandemic on healthcare and well- being 
among clinical responders which will help tailor interven-
tions and provide data for future planning of psycholog-
ical support.
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